Chison Medical Technologies Stock Working Capital
| 688358 Stock | 26.51 0.24 0.91% |
Chison Medical Technologies fundamentals help investors to digest information that contributes to Chison Medical's financial success or failures. It also enables traders to predict the movement of Chison Stock. The fundamental analysis module provides a way to measure Chison Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chison Medical stock.
As of December 2, 2024, Net Working Capital is expected to decline to about 953.2 M. In addition to that, Change In Working Capital is expected to decline to about (44.5 M). Chison | Working Capital |
Chison Medical Technologies Company Working Capital Analysis
Chison Medical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Chison Medical Working Capital | 1.2 B |
Most of Chison Medical's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chison Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Chison Net Invested Capital
Net Invested Capital |
|
In accordance with the company's disclosures, Chison Medical Technologies has a Working Capital of 1.2 B. This is 182.61% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The working capital for all China stocks is 18.62% higher than that of the company.
Chison Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chison Medical's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chison Medical could also be used in its relative valuation, which is a method of valuing Chison Medical by comparing valuation metrics of similar companies.Chison Medical is currently under evaluation in working capital category among its peers.
Chison Fundamentals
| Current Valuation | 1.91 B | ||||
| Price To Book | 2.16 X | ||||
| Price To Sales | 6.55 X | ||||
| Revenue | 483.84 M | ||||
| EBITDA | 125.83 M | ||||
| Net Income | 146.48 M | ||||
| Total Debt | 4.02 M | ||||
| Cash Flow From Operations | 85.91 M | ||||
| Market Capitalization | 3.55 B | ||||
| Total Asset | 1.52 B | ||||
| Retained Earnings | 305.98 M | ||||
| Working Capital | 1.2 B | ||||
| Net Asset | 1.52 B |
About Chison Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chison Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chison Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chison Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Chison Stock
Chison Medical financial ratios help investors to determine whether Chison Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chison with respect to the benefits of owning Chison Medical security.